跳至主要内容
临床试验/ISRCTN64752662
ISRCTN64752662已完成不适用

Regenerative therapy of intervertebral disc using platelet-rich plasma growth factors

Mie University Graduate School of Medicine0 个研究点目标入组 10 人开始时间: 2015年5月23日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged >18
  • 2. Chronic low back pain without leg pain for more than 3 months
  • 3. One or more lumbar discs (L3/L4 to L5/S1) with evidence of degenerative changes on magnetic resonance imaging (MRI) maintenance of 50% or more of normal disc height
  • 4. At least one symptomatic disc confirmed using standardised provocative discography and/or disc block

排除标准

  • 1. Abnormal neurological symptoms (e.g. radiculopathy) with lumbar spinal stenosis or spondylolisthesis
  • 2. Inflammatory arthritis (e.g. discitis)

研究者

发起方
Mie University Graduate School of Medicine

相似试验

进行中(未招募)
1 期
Efficacy of intradiscal injection of cells from the bone marrow in subjects with chronic back pain, caused by a degenerative disease affecting the vertebral idisc,which does not respond to traditional therapy.Symptomatic chronic low back pain due to a degenerative disease of the intervertebral discMedDRA version: 21.0Level: LLTClassification code 10070241Term: Degenerative disc diseaseSystem Organ Class: 100000004859
EUCTR2019-002749-40-ITIVERSITÀ CAMPUS BIO-MEDICO DI ROMA52
进行中(未招募)
1 期
Treatment of arthrosis of the lumbar spine with own stem cells from bonemarrow
EUCTR2012-003160-44-DKOrthopaedic Research Laboratory, Århus University Hospital
进行中(未招募)
1 期
Treatment of degenerative disc disease with allogenic mesenchymal cells—MSVTreatment of degenerative disc disease
EUCTR2012-004444-30-ESCitospin
招募中
1 期
Clinical Trial on the Repair of Intervertebral Disc Injury by Bushen Huoxue Prescriptio
ITMCTR2024000022China Academy of Chinese Medical Sciences Wangjing Hospital
进行中(未招募)
不适用
Regeneración del disco intervertebral lumbar mediante MSV*”*Células progenitoras de médula ósea autóloga, expandidas Ex Vivo” con procedimiento GMP del Instituto de Biología y Genética Molecular de ValladolidPacientes con enfermedad degenerativa de uno o dos discos lumbares con predominio de dolor lumbar y/o citalagia persistente tras tratamiento conservador (médico y fisioteràpico) de mas de 6 meses de evolución.
EUCTR2008-001191-68-ESInstitut de Terapia Regenerativa Tissular (ITRT)